Absci (ABSI) Acquisitions (2021 - 2022)
Absci's (ABSI) quarterly Acquisitions came in at $8.0 million in Q2 2022, down 68.77% year-on-year from $25.6 million in Q2 2021, and down 68.77% quarter-over-quarter from $25.6 million in Q2 2021.
Absci (ABSI) Acquisitions (2021 - 2022) Analysis & Trends
Absci has disclosed Acquisitions across 2 years of filings, most recently posting $8.0 million for Q2 2022.
- Acquisitions for Q2 2022 came in at $8.0 million, down 68.77% year-over-year; the trailing twelve-month figure through Sep 2023 was $8.0 million (changed 0.0% YoY), and the FY2022 annual result was $8.0 million, down 71.56% from the prior year.
- Acquisitions came in at $8.0 million for Q2 2022 at Absci, down from $25.6 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $25.6 million in Q2 2021 to a low of $2.5 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 8.00 Mn |
| Jun 30, 2021 | 25.62 Mn |
| Mar 31, 2021 | 2.51 Mn |